Cathepsin cysteine protease inhibitors

Details Cathepsin cysteine protease inhibitors Cathepsin cysteine protease inhibitors

2005-11-18

2008-08-05

Wilson, James O. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S357000, C514S365000, C544S393000, C544S400000, C546S300000, C548S204000, C548S205000, C558S404000, C558S414000, C558S431000, C558S434000

Reexamination Certificate

active

07407959

ABSTRACT:
This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.

REFERENCES:
patent: 2003/0232863 (2003-12-01), Bayly et al.
patent: 2005/0014941 (2005-01-01), Black et al.
patent: 2005/0182096 (2005-08-01), Link et al.
patent: 2005/0240023 (2005-10-01), Bayly et al.
patent: 2 439 415 (2002-09-01), None
patent: WO 99/24460 (1999-05-01), None
patent: WO 03/075836 (2003-09-01), None
Alessandro Volonterio, et al. “Synthesis of Partially Modified Retro and Retroinverso [NHCH(CF3)]-Peptides,” Organic Letters 2000, vol. 2, No. 13, 1827-1830.
Alessandro Volonterio, et al. “Solution/solid-phase synthesis of partially modified retro-[NHCH(CF3)]-peptidyl hydroxamates,” Tetrahedron Letters 42 (2001), 3141-3144.
Alessandro Volonterio, et al. “Solid-phase synthesis of partially-modified retro and retro-inverso [NHCH(CF3)]-peptides,” Tetrahedron Letters 41 (2000) 6517-6521.
Ishii, et al. “Asymmetric Addition Reactions of Grignard Reagents to Chiral Fluoral Hemiacetal: Asymmetric Synthesis of 1-Substituted-2,2,2,-Trifluoroethylamines,” Synlett, Dec. 1997, 1381-1382.
Ishii, et al. “Stereospecific Reduction with Retention of Chiral Fluoral-derived 1,3-Oxazolidines with LiAlH4: Asymmetric Synthesis of 1-Substituted 2,2,2-Trifluoroethylamines,” Chem. Letters 1998, 119-120.
Robichaud, J et al., Biorganic & Medicinal Chemistry Letters 14, pp. 4291-4295 (2004), “Rational design of potent and selective NH-linked aryl/heteroaryl cathepsin K inhibitors”.

Affiliated with

Also associated with

Rating

Cathepsin cysteine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cathepsin cysteine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cathepsin cysteine protease inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4009913